Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Wenkert Deborah — Inozyme Pharma, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / Wenkert Deborah

Wenkert Deborah

SVP, CMO at Inozyme Pharma, Inc. · on record since Feb 4, 2021

Insider trading activity of Wenkert Deborah

Transactions on record: 1; since Feb 4, 2021

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Feb 4, 2021

Figures computed from official regulatory filings — methodology.

Companies where Wenkert Deborah has traded

Inozyme Pharma, Inc.1 tx · Feb 4, 2021

Track record of Wenkert Deborah

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Wenkert Deborah

Co-insiders of Wenkert Deborah

ALEXION PHARMACEUTICALS INCInozyme Pharma, Inc.
BASKETT FORESTInozyme Pharma, Inc.
Basso StephenInozyme Pharma, Inc.
Bhagat Sarah MInozyme Pharma, Inc.
Bjarke Henric BjornInozyme Pharma, Inc.
Bolte AxelInozyme Pharma, Inc.
Braddock DemetriosInozyme Pharma, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

DIAZ REINALDO MInozyme Pharma, Inc.

DiPalma Stephen J.Inozyme Pharma, Inc.

Edwards MartinInozyme Pharma, Inc.

ENRIGHT PATRICK GInozyme Pharma, Inc.

Florence Anthony A. Jr.Inozyme Pharma, Inc.

Harris ErikInozyme Pharma, Inc.

HEALY JAMESInozyme Pharma, Inc.

Hopfner Robert LorneInozyme Pharma, Inc.

Huertas PedroInozyme Pharma, Inc.

Inozyme Pharma, Inc.Inozyme Pharma, Inc.

Jungles Steven JInozyme Pharma, Inc.

Katabi MahaInozyme Pharma, Inc.

Kolchinsky PeterInozyme Pharma, Inc.

Longitude Capital Partners III, LLCInozyme Pharma, Inc.

Longitude Venture Partners III, L.P.Inozyme Pharma, Inc.

Makhzoumi MohamadInozyme Pharma, Inc.

MAKOWER JOSHUAInozyme Pharma, Inc.

Mathers Edward TInozyme Pharma, Inc.

NEA 15 GP, LLCInozyme Pharma, Inc.

NEA Partners 15, L.P.Inozyme Pharma, Inc.

New Enterprise Associates 15, L.P.Inozyme Pharma, Inc.

Novo A/SInozyme Pharma, Inc.

Pivotal bioVenture Partners Fund I G.P., L.P.Inozyme Pharma, Inc.

Pivotal bioVenture Partners Fund I, L.P.Inozyme Pharma, Inc.

Pivotal bioVenture Partners Fund I U.G.P., LtdInozyme Pharma, Inc.

POWELL MICHAELInozyme Pharma, Inc.

RA CAPITAL MANAGEMENT, LLCInozyme Pharma, Inc.

Rock Springs Capital LLCInozyme Pharma, Inc.

Rock Springs Capital Management LPInozyme Pharma, Inc.

Rock Springs Capital Master Fund LPInozyme Pharma, Inc.

SANDELL SCOTT DInozyme Pharma, Inc.

SANOFI-AVENTISInozyme Pharma, Inc.

Schlessinger JosephInozyme Pharma, Inc.

Shah Rajeev M.Inozyme Pharma, Inc.

Sofinnova Management X, L.L.C.Inozyme Pharma, Inc.

Sofinnova Venture Partners X, L.P.Inozyme Pharma, Inc.

Sonsini Peter W.Inozyme Pharma, Inc.

Subramanian SanjayInozyme Pharma, Inc.

Sullivan Lynne MarieInozyme Pharma, Inc.

Tammenoms Bakker JulietInozyme Pharma, Inc.

Treco Douglas AInozyme Pharma, Inc.

Winton MatthewInozyme Pharma, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Inozyme Pharma, Inc.	Feb 4, 2021	AwardD	100,000	0.00 USD	$0	SEC